Orias VM

Language: Spanish
References: 16
Page: 1-11
PDF size: 190.77 Kb.

ABSTRACT

Polycystic ovary syndrome is the most common endocrinopathies in women. It mainly affects women of reproductive age. It is a disease of unknown etiology, but it is believed to be multifactorial. It manifests clinically with menstrual alterations, infertility, hirsutism, acne, obesity, and insulin resistance. For its diagnosis, it is necessary to exclude other pathologies that cause disorders of the menstrual cycle and excess androgens, and meet at least two of the following criteria: oligomenorrhea / amenorrhea, clinical and / or biochemical hyperandrogenism, polycystic ovaries by ultrasound. Treatment should be individualized and focused on the regulation of menstrual disorders and the patient's desire to conceive.

REFERENCES

1. Rosenfield R, Ehrmann D. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews. 2016;37(5):467-520.

2. Dumesic D, Oberfield S, Stener-Victorin E, Marshall J, Laven J, Legro R. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocrine Reviews [Internet]. 2015 [cited 9 August 2020];36(5):487-525. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591526/?report=printable

3. Sanchez Gaitan E. Actualización del manejo de síndrome de ovario poliquístico. Revista Médica Sinergia [Internet]. 2019 [cited 9 August 2020];4(12):e322. Available from: https://revistamedicasinergia.com/index.php/rms

4. Mahalingaiah S, Diamanti-Kandarakis E. Targets to treat metabolic syndrome in polycystic ovary syndrome. Expert Opinion on Therapeutic Targets. 2015;19(11):1561-1574.

5. Witchel S, Oberfield S, Peña A. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. Journal of the Endocrine Society. 2019;3(8):1545-1573.

6. Pérez Rojas J, Maroto Fernandez K. Síndrome de Ovarios Poliquísticos. Medicina Legal de Costa Rica Edición Virtual. 2018;35(1):1-8.

7. Practice Bulletin No. 131. Polycystic Ovary Syndrome. Obstetrics & Gynecology. 2018;131(6):1174-1176.

8. Barbieri, MD R, Ehrmann, MD D. Diagnosing Polycystic Ovary Syndrome in Adults [Internet]. www.uptodate.com. 2018 [cited 9 August 2020]. Available from: https://www.uptodate.com/contents/diagnosis-of-polycystic-ovarysyndrome- in-adults/contributors

9. Barbieri, MD R, Ehrmann, MD D. Clinical manifestations of polycystic ovary syndrome in adults [Internet]. www.uptodate.com. 2020 [cited 9 August 2020]. Available from: https://www.uptodate.com/contents/clinicalmanifestations- of-polycystic-ovary-syndrome-in-adults/print?search=sindrome

10. Muñoz Calvo. M. Síndrome de Ovario Poliquístico (SOP). Revista de Formación Continuada de la Sociedad Española de Medicina de la Adolescencia. 2016;4(2):20-31.

11. Winnykamien I, Dalibón A, Knoblovits P. Síndrome de ovario poliquístico. Revista del Hospital de Italiano Buenos Aires. 2017;37(1):10-20.

12. Gamboa I, Prez M. Síndrome de ovario poliquístico: revisión bibliográfica. Revista médica de Costa Rica y Centroamerica. 2015; LXXII(614):175-181.

13. McCartney C, Marshall J. Polycystic Ovary Syndrome. New England Journal of Medicine. 2016;375(1):54-64.

14. De Sousa S, Norman R. Metabolic syndrome, diet and exercise. Best Practice & Research Clinical Obstetrics & Gynaecology [Internet]. 2016 [cited 10 August 2020];37:140-151. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1521693416000079?via%3Dihub

15. Barbieri, MD R, Ehrmann, MD D. Metformin for treatment of the polycystic ovary syndrome [Internet]. Uptodate.com. 2018 [cited 10 August 2020]. Available from: https://www.uptodate.com/contents/metformin-fortreatment- of-the-polycystic-ovary-syndrome#!

16. Barbieri, MD R, Ehrmann, MD D. Treatment of polycystic ovary syndrome in adults [Internet]. uptodate. 2020 [cited 10 August 2020]. Available from: https://www.uptodate.com